Budget Impact Associated with the Introduction of the Impella 5.0^® Mechanical Circulatory Support Device for Cardiogenic Shock in France

References

• Van Diepen S, Katz JN, Albert NM, et al., American Heart Association Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Quality of Care and Outcomes Research; and Mission: Lifeline. Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association. Circulation. 2017;136(16):e232–e268. doi:10.1161/CIR.0000000000000525
   PubMed Web of Science ®Google Scholar
• Ponikowski P, Voors AA, Anker SD, et al., ESC Scientific Document Group. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129–2200. doi:10.1093/eurheartj/ehw128
   PubMed Web of Science ®Google Scholar
• Thiele H, Ohman EM, Desch S, Eitel I, de Waha S. Management of cardiogenic shock. Eur Heart J. 2015;36(20):1223–1230. doi:10.1093/eurheartj/ehv051
   Web of Science ®Google Scholar
• Kolte D, Khera S, Aronow WS, et al. Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States. J Am Heart Assoc. 2014;3(1):e000590. doi:10.1161/JAHA.113.000590
   PubMed Web of Science ®Google Scholar
• Ollivier J, Fresselinat A, Seguy B, et al. The use of Impella 5.0 in refractory cardiogenic shock: a medico-economic report. Pharm J Med Devices. 2019;1. Available from: https://www.euro-pharmat.com/la-revue-du-dm. Accessed March 17, 2020.
   Google Scholar
• van Diepen S, Thiele H. An overview of international cardiogenic shock guidelines and application in clinical practice. Curr Opin Crit Care. 2019;25(4):365–370. doi:10.1097/MCC.0000000000000624
   PubMed Web of Science ®Google Scholar
• Bonello L, Delmas C, Schurtz G, et al. Mechanical circulatory support in patients with cardiogenic shock in intensive care units: a position paper of the “Unité de Soins Intensifs de Cardiologie” group of the French Society of Cardiology, endorsed by the “Groupe Athérome et Cardiologie Interventionnelle” of the French Society of Cardiology. Arch Cardiovasc Dis. 2018;111(10):601–612. doi:10.1016/j.acvd.2018.03.008
   Web of Science ®Google Scholar
• Gaudard P, Mourad M, Eliet J, et al. Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock. Crit Care. 2015;19:363. doi:10.1186/s13054-015-1073-8
   PubMed Web of Science ®Google Scholar
• Seese L, Hickey G, Keebler ME, et al. Direct bridging to cardiac transplantation with the surgically implanted Impella 5.0 device. Clin Transplant. 2020;34(3):e13818. doi:10.1111/ctr.13818
   Web of Science ®Google Scholar
• Lemaire A, Anderson MB, Lee LY, et al. The Impella device for acute mechanical circulatory support in patients in cardiogenic shock. Ann Thorac Surg. 2014;97(1):133–138. doi:10.1016/j.athoracsur.2013.07.053
   PubMed Web of Science ®Google Scholar
• Batsides G, Massaro J, Cheung A, Soltesz E, Ramzy D, Anderson MB. Outcomes of Impella 5.0 in cardiogenic shock: a systematic review and meta-analysis. Innovations (Phila). 2018;13(4):254–260. doi:10.1097/IMI.0000000000000535
   Google Scholar
• Glazier JJ, Kaki A. The Impella device: historical background, clinical applications and future directions. Int J Angiol. 2019;28(2):118–123. doi:10.1055/s-0038-1676369
   Web of Science ®Google Scholar
• Bonello L, Delmas C, Gaubert M, Schurtz G, Ouattara A, Roubille F. Trials of mechanical circulatory support with percutaneous axial flow pumps in cardiogenic shock complicating acute myocardial infarction: mission impossible? Arch Cardiovasc Dis. 2020;113(6–7):448–460. doi:10.1016/j.acvd.2020.02.001
   Web of Science ®Google Scholar
• Karami M, den Uil CA, Ouweneel DM, et al. Mechanical circulatory support in cardiogenic shock from acute myocardial infarction: Impella CP/5.0 versus ECMO. Eur Heart J Acute Cardiovasc Care. 2019;2048872619865891. doi:10.1177/2048872619865891
   Web of Science ®Google Scholar
• Chevreul K, Berg Brigham K, Durand-Zaleski I, Hernandez-Quevedo C. France: health system review. Health Syst Transit. 2015;17(3):1–21.
   PubMedGoogle Scholar
• Haute Autorité de Santé. Impella 5.0 March 2020. Available from: https://www.has-sante.fr/upload/docs/evamed/CNEDIMTS-5865_IMPELLA%205%200_24_mars_2020_(5865)_avis.pdf. Accessed October 12, 2020.
   Google Scholar
• Cheng R, Hachamovitch R, Kittleson M, et al. Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: a meta-analysis of 1866 adult patients. Ann Thorac Surg. 2014;97(2):610–616.
   PubMed Web of Science ®Google Scholar
• Agence Technique de l’Information sur l’Hospitalisation. Guide d’utilisation: valorisation de l’activité 2018 par les tariffs 2018 et par les tariffs 2019. Available from: https://www.atih.sante.fr/sites/default/files/public/content/3592/guide_dutilisation_-_valorisation_de_lactivite_2018_par_les_tarifs_2018_et_tarifs_2019.pdf. Accessed February 20, 2020.
   Google Scholar
• Halimi S, Benhamou PY, Charras H. Le cout du pied diabetique. Available from: https://www.fmc-tourcoing.org/PROGRAMME_FMC/DIABETE_10_00/DIABETEFMI/cout-pied-3.html. Accessed February 20, 2020.
   Google Scholar
• Liste des Produits et Prestations Remboursables. Available from: https://www.ameli.fr/sites/default/files/Documents/615994/document/lpp.pdf. Accessed March 18, 2020.
   Google Scholar
• Ghabri S, Autin E, Poullié AI, Josselin JM. The French National Authority for Health (HAS) guidelines for conducting Budget Impact Analyses (BIA). Pharmacoeconomics. 2018;36(4):407–417. doi:10.1007/s40273-017-0602-5
   PubMed Web of Science ®Google Scholar
• Sullivan SD, Mauskopf JA, Augustovski F, et al. Budget impact analysis-principles of good practice: report of the ISPOR 2012 budget impact analysis good practice II task force. Value Health. 2014;17(1):5–14. doi:10.1016/j.jval.2013.08.2291
   PubMed Web of Science ®Google Scholar
• Puymirat E, Fagon JY, Aegerter P, et al; Collège des Utilisateurs de Bases de données en Réanimation (CUB-Réa Group [Intensive Care Database User Group]). Cardiogenic shock in intensive care units: evolution of prevalence, patient profile, management and outcomes, 1997–2012. Eur J Heart Fail. 2017;19(2):192–200. doi:10.1002/ejhf.646
   PubMed Web of Science ®Google Scholar
• El Sibai R, Bachir R, El Sayed M. Outcomes in cardiogenic shock patients with extracorporeal membrane oxygenation use: a matched cohort study in hospitals across the United States. Biomed Res Int. 2018;2018:2428648.
   Web of Science ®Google Scholar
• Lamarche Y, Cheung A, Ignaszewski A, et al. Comparative outcomes in cardiogenic shock patients managed with Impella microaxial pump or extracorporeal life support. J Thorac Cardiovasc Surg. 2011;142(1):60–65. doi:10.1016/j.jtcvs.2010.07.075
   PubMed Web of Science ®Google Scholar
• Esposito ML, Jablonski J, Kras A, Krasney S, Kapur NK. Maximum level of mobility with axillary deployment of the Impella 5.0 is associated with improved survival. Int J Artif Organs. 2018;41(4):236–239. doi:10.1177/0391398817752575
   PubMed Web of Science ®Google Scholar
• Sassard T, Scalabre A, Bonnefoy E, Sanchez I, Farhat F, Jegaden O. The right axillary artery approach for the Impella recover LP 5.0 microaxial pump. Ann Thorac Surg. 2008;85(4):1468. doi:10.1016/j.athoracsur.2007.09.017
   Web of Science ®Google Scholar
• Griffith BP, Anderson MB, Samuels LE, Pae WE Jr, Naka Y, Frazier OH. The RECOVER I: a multicenter prospective study of Impella 5.0/LD for postcardiotomy circulatory support. J Thorac Cardiovasc Surg. 2013;145(2):548–554. doi:10.1016/j.jtcvs.2012.01.067
   PubMed Web of Science ®Google Scholar
• Moazzami K, Dolmatova EV, Cocke TP, et al. Left ventricular mechanical support with the Impella during extracorporeal membrane oxygenation. J Tehran Heart Cent. 2017;12(1):11–14.
   PubMedGoogle Scholar
• Curran J, Burkhoff D, Kloner RA. Beyond reperfusion: acute ventricular unloading and cardioprotection during myocardial infarction. J Cardiovasc Transl Res. 2019;12(2):95–106. doi:10.1007/s12265-019-9863-z
   Web of Science ®Google Scholar
• Stone GW, Selker HP, Thiele H, et al. Relationship between infarct size and outcomes following primary PCI: patient-level analysis from 10 randomized trials. J Am Coll Cardiol. 2016;67(14):1674–1683. doi:10.1016/j.jacc.2016.01.069
   PubMed Web of Science ®Google Scholar
• Schrage B, Becher PM, Bernhardt A, et al. Left ventricular unloading is associated with lower mortality in patients with cardiogenic shock treated with venoarterial extracorporeal membrane oxygenation: results from an international, Multicenter Cohort Study. Circulation. 2020;142(22):2095–2106. doi:10.1161/CIRCULATIONAHA.120.048792
   PubMed Web of Science ®Google Scholar